These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 30056911

  • 1. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018; 50(6):1838-1841. PubMed ID: 30056911
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018; 50(6):1834-1837. PubMed ID: 30056910
    [Abstract] [Full Text] [Related]

  • 3. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B, Canver B, Gurlek Demirci B, Colak T, Ozdemir BH, Haberal M.
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [Abstract] [Full Text] [Related]

  • 4. Early inhibition of the renin-angiotensin system improves the long-term graft survival of single pediatric donor kidneys transplanted in adult recipients.
    Zhang R, Laguardia H, Paramesh A, Mills K, Killackey M, McGee J, Alper B, Simon E, Lee Hamm L, Slakey D.
    Transpl Int; 2013 Jun; 26(6):601-7. PubMed ID: 23506676
    [Abstract] [Full Text] [Related]

  • 5. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
    Karabsheh S, Verma DR, Jain M, Stoddard G, Brunisholz K, Stehlik J, Kfoury A, Gilbert E, Bader F.
    Am J Cardiol; 2011 Dec 15; 108(12):1836-9. PubMed ID: 22133132
    [Abstract] [Full Text] [Related]

  • 6. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
    Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA.
    Am J Kidney Dis; 2017 Jan 15; 69(1):78-86. PubMed ID: 27712852
    [Abstract] [Full Text] [Related]

  • 7. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF.
    Nephrol Dial Transplant; 2004 Nov 15; 19(11):2852-7. PubMed ID: 15466882
    [Abstract] [Full Text] [Related]

  • 8. Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials.
    Liao RX, Lyu XF, Tang WJ, Gao K.
    Clin Transplant; 2017 Apr 15; 31(4):. PubMed ID: 28186357
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin-aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels.
    Mikolasevic I, Zaputovic L, Zibar L, Begic I, Zutelija M, Klanac A, Majurec I, Simundic T, Minazek M, Orlic L.
    Eur J Intern Med; 2016 Apr 15; 29():98-103. PubMed ID: 26775133
    [Abstract] [Full Text] [Related]

  • 10. The renin angiotensin system blockade in kidney transplantation: pros and cons.
    Cruzado JM, Rico J, Grinyó JM.
    Transpl Int; 2008 Apr 15; 21(4):304-13. PubMed ID: 18266774
    [Abstract] [Full Text] [Related]

  • 11. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F, Valladares J, Díaz-Campillejo R, Barroso S, Luna E, Caravaca F.
    Nefrologia (Engl Ed); 2020 Apr 15; 40(1):38-45. PubMed ID: 31196659
    [Abstract] [Full Text] [Related]

  • 12. Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan.
    Tsuchimoto A, Masutani K, Ueki K, Nakagawa K, Matsukuma Y, Tanaka S, Unagami K, Kakuta Y, Okumi M, Noguchi H, Kaku K, Okabe Y, Nakano T, Kitazono T, Nakamura M, Ishida H, Tanabe K, Japan Academic Consortium of Kidney Transplantation (JACK) Investigators.
    Clin Exp Nephrol; 2020 Apr 15; 24(4):369-378. PubMed ID: 31875930
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 14. The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients - a cross-sectional prospective observational clinical study.
    Heleniak Z, Illersperger S, Brakemeier S, Bach P, Dębska-Ślizień A, Budde K, Halleck F.
    Acta Biochim Pol; 2020 Dec 17; 67(4):613-622. PubMed ID: 33332078
    [Abstract] [Full Text] [Related]

  • 15. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
    Voskamp PWM, Dekker FW, van Diepen M, Hoogeveen EK, PREPARE-2 Study Group.
    J Am Soc Hypertens; 2017 Oct 17; 11(10):635-643. PubMed ID: 28802945
    [Abstract] [Full Text] [Related]

  • 16. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
    González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM.
    Transplant Proc; 2010 Oct 17; 42(8):2899-901. PubMed ID: 20970564
    [Abstract] [Full Text] [Related]

  • 17. Improvement of Blood Pressure Control in Renal Transplant Recipients-Retrospective Longitudinal Study.
    Adrych D, Kuźmiuk-Glembin I, Tylicki L, Heleniak Z, Garnier H, Wiśniewski J, Rutkowski P, Rutkowski B, Dębska-Ślizień A.
    Transplant Proc; 2018 Oct 17; 50(1):155-159. PubMed ID: 29407301
    [Abstract] [Full Text] [Related]

  • 18. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Oct 17; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
    Goel SS, Aksoy O, Gupta S, Houghtaling PL, Tuzcu EM, Marwick T, Mihaljevic T, Svensson L, Blackstone EH, Griffin BP, Stewart WJ, Barzilai B, Menon V, Kapadia SR.
    Ann Intern Med; 2014 Nov 18; 161(10):699-710. PubMed ID: 25402513
    [Abstract] [Full Text] [Related]

  • 20. Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
    Salzberg DJ.
    Curr Hypertens Rep; 2007 Nov 18; 9(5):422-9. PubMed ID: 18177591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.